Category: North America

January 13, 2025 Off

Moderna achieves $3B in product sales in 2024

By Dino Mustafić

Moderna announced Monday business updates and progress across its pipeline of mRNA medicines, entering 2025 with a focus on a prioritized portfolio addressing respiratory viruses, rare diseases, oncology, and latent and other viruses where there is unmet need, as it achieved $3-3.1B in product sales.